Therapeutical use of known 5-aminomethyl oxazolidine-2-one derivatives
US4470993A · kind A · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 1983 |
| Grant date | Sep 11, 1984 |
| Priority date | — |
| Expiry date | Mar 3, 2003 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of treating the central nervous system troubles such as the Parkinson's disease and the senescence troubles, generally treated by the B type monoamine oxidase inhibitors, which comprises administering internally to a human being requiring such treatment a therapeutically effective amount of N-aryl 5-aminomethyl oxazolidine-2-one derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.